参考文献/References:
[1] Li J, Xue H, Li T, et al. Exosomes?derived from mesenchymal stem cells attenuate the progression of atherosclerosis in ApoE-/-?mice via miR-let7 mediated infiltration and polarization of M2 macrophage[J]. Biochem Biophys Res Commun,2019,510(4):565-572.
[2] Jin H, Wang H, Li J, et al. Differential contribution of the two waves of?cardiac?progenitors and their derivatives to aorta and pulmonary artery[J]. Dev Biol,2019, S0012-1606(18) :30807-30818.
[3] Vizoso FJ, Eiro N, Cid S, et al. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine[J].?Int J Mol Sci,2017,18(9):1852-1864.
[4] Tian C, Gao L, Zimmerman MC, et al. Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure[J].?Am J Physiol Heart Circ Physiol,2018,314(5):928 -939.
[5] Yang Y, Li Y, Chen X, et al. Exosomal transfer of miR-30a between cardiomyocytes regulates autophagy after hypoxia[J].?J Mol Med,2016,94(6):711-724.
[6] Nie X, Fan J, Li H, et al. MiR-217 promotes cardiac hypertrophy and dysfunction by targeting PTEN[J].?Mol Ther Nucleic Acids,?2018,12(9):254-266.
[7] Cosme J, Guo H, Hadipour-Lakmehsari S, et al . Hypoxia-induced changes in the fibroblast s ecretome, exosome, and whole-cell proteome using cultured, cardiac-derived cells isolated from neonatal mice[J].?J Proteome Res, 2017,16(8):2836-2847.
[8] 徐佳,孙林.冠状动脉慢血流现象的风险标志物及预测因子的研究进展[J].心血管病学进展,2019,40(2):238-242.
[9] Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: Current perspectives and future challenges[J].?Acta Pharm Sin B,2016,6(4):287-296.
[10] Tang YT, Huang YY, Zheng L, et al. Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum[J].?Int J Mol Med,?2017,40(3):834-844.
[11] Barile L, Cervio E, Lionetti V, et al. Cardioprotection by cardiac progenitor cell-secreted?exosomes: role of pregnancy-associated plasma protein-A[J]. Cardiovasc Res, 2018,114(7):992-1005.
[12] Wu W, Li X, Zuo G, et al. The role of angiogenesis incoronaryarterydisease:a double-edged sword: intraplaque angiogenesis in physiopathology and therapeutic angiogenesis for treatment[J]. Curr Pharm Des,2018,24(4):451-464.
[13] Barani B, Rajasingh S, Rajasingh J. Exosomes:outlook for future cell-free cardiovasculardiseasetherapy[J].Adv Exp Med Biol,2017,998(6):285-307.
[14] Chang TY, Tsai WC, Huang TS, et al.Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular?disease?patients[J]. PLoS One, 2017 ,12(7):e0181562.
[15] Boulanger CM, Loyer X, Rautou PE, et al. Extracellular vesicles in?coronary?artery?disease[J].Nat Rev Cardiol, 2017,14(5):259-272.
[16] Barile L, Cervio E, Lionetti V, et al. Cardioprotection by cardiac progenitor cell-secreted exosomes: Role of pregnancy-associated plasma protein-A[J].?Cardiovasc Res,2018,114(7): 992-1005.
[17] Nie S, Wang X, Sivakumaran P, et al. Biologically active constituents of the secretome of human W8B2+ cardiac stem cells[J].?Sci Rep,2018,8(1):1579.
[18] Cheow ES, Cheng WC, Lee CN,et al. Plasma-derived extracellular vesicles contain predictive biomarkers and potential therapeutic targets for myocardial ischemic (MI) injury[J].?Mol Cell Proteomics,2016,15(8):2628-2640.
[19] Cambria E, Pasqualini FS, Wolint P, et al. Translational cardiac stem cell therapy: Advancing from first-generation to next-generation cell types[J].?NPJ Regen Med,2017, 2(6):17-26.
[20] Middleton RC, Rogers RG, de Couto G, et al. Newt cells secrete extracellular vesicles with therapeutic bioactivity in mammalian cardiomyocytes[J].?J Extracell Vesicles,2018,7(1): 1456888.
[21] Kim MS, Haney MJ, Zhao Y, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells[J].?Nanomedicine,2016,12(3):655-664.
[22] Gallet R, Dawkins J, Valle J, et al. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction[J].?Eur Heart J,2017,38(3):201-211.
[23] Vandergriff A, Huang K, Shen D, et al. Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide[J].?Theranostics,?2018,8(7):1869-1878.
[24] Kim H, Yun N, Mun D, et al. Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes[J].?Biochem Biophys Res Commun,2018,499(4):803-808.
[25] Wang X, Chen Y, Zhao Z, et al. Engineered exosomes with ischemic myocardium-targeting peptide for targeted therapy in myocardial infarction[J].?J Am Heart Assoc,2018,7(15):e008737-e008753.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(6):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(6):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]宋菲,综述,俞梦越,等.干细胞来源的外泌体:心肌梗死治疗新启示[J].心血管病学进展,2016,(2):125.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.007]
SONG Fei,YU Mengyue.Exosomes Derived from Stem Cells: Novel Approach in Treatment of
Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(6):125.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.007]
[4]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for
Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(6):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[5]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(6):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[6]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(6):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[7]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(6):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[8]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(6):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[9]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[10]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(6):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]